These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12765219)

  • 1. Protective effect of leukotriene receptor antagonist montelukast on smoking-induced lung injury in Wistar rats.
    Yüksel H; Ozbilgin K; Coskun S; Tuglu I
    Acta Med Okayama; 2003 Feb; 57(1):13-9. PubMed ID: 12765219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast does not protect against hyperoxia-induced inhibition of alveolarization in newborn rats.
    Jouvencel P; Fayon M; Choukroun ML; Carles D; Montaudon D; Dumas E; Begueret H; Marthan R
    Pediatr Pulmonol; 2003 Jun; 35(6):446-51. PubMed ID: 12746941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
    Cikler E; Ersoy Y; Cetinel S; Ercan F
    Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
    Al-Amran FG; Hadi NR; Hashim AM
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
    Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
    Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotrienes produced in allergic lung inflammation activate alveolar macrophages.
    Silva RC; Landgraf MA; Hiyane MI; Pacheco-Silva A; Câmara NO; Landgraf RG
    Cell Physiol Biochem; 2010; 26(3):319-26. PubMed ID: 20798516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
    Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
    Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats.
    Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N
    Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
    Ibrahim MA; Amin EF; Ibrahim SA; Abdelzaher WY; Abdelrahman AM
    Eur J Pharmacol; 2014 Feb; 724():204-10. PubMed ID: 24370493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
    Shiota N; Shimoura K; Okunishi H
    Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
    Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of montelukast and MK-886 on hepatic ischemia-reperfusion injury in rats.
    Daglar G; Karaca T; Yuksek YN; Gozalan U; Akbiyik F; Sokmensuer C; Gurel B; Kama NA
    J Surg Res; 2009 May; 153(1):31-8. PubMed ID: 18656901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast protects against renal ischemia/reperfusion injury in rats.
    Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
    Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats.
    Ozkan E; Akyüz C; Sehirli AO; Topaloğlu U; Ercan F; Sener G
    Pancreas; 2010 Oct; 39(7):1041-6. PubMed ID: 20467345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
    Biber N; Toklu HZ; Solakoglu S; Gultomruk M; Hakan T; Berkman Z; Dulger FG
    Brain Inj; 2009 Jun; 23(6):577-84. PubMed ID: 19484631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.
    Mohamed MZ; Zenhom NM
    Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.